TRANSMAB Trademark Information

Trademark by InNexus Biotechnology International Limited

Medical and scientific research, namely, production of novel antibodies for targeting and regulating intracellular proteins, and consultation provided in connection therewith

Classification Information

Use in Commerce Trademark - Applicant has provided proof of use of this mark in commerce to USPTO.

Primary Class: Class Details:
Class (042)
Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
First Use Anywhere:: 2/1/2005
First Use In Commerce: 2/1/2005
General Information
Word mark: TRANSMAB
Status/Status Date:
CONTINUED USE NOT FILED WITHIN GRACE PERIOD, UN-REVIVABLE
1/31/2014
Serial Number: 78812778
Filing Date: 2/11/2006
Registration Number: 3255349
Registration Date: 6/26/2007
Goods and Services: Medical and scientific research, namely, production of novel antibodies for targeting and regulating intracellular proteins, and consultation provided in connection therewith
Mark Description: NOT AVAILABLE
Type Of Mark: Service Mark
Published For Opposition Date: 4/10/2007
Last Applicant/Owner:
InNexus Biotechnology International Limited
Scottsdale, AZ 85259
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
MEDICUS ASSOCIATES
MEDICUS ASSOCIATES 2804 KENTUCKY AVE.
JOPLIN MO 64804
Current Status:
CONTINUED USE NOT FILED WITHIN GRACE PERIOD, UN-REVIVABLE
1/31/2014
Correspondent Search:
JAMES H. MEADOWS is a correspondent of TRANSMAB trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on